Status:

COMPLETED

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions:

Healthy

Estrogen Replacement Therapy

Eligibility:

FEMALE

35-95 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to assess the immunological status of patients using Premarin. Premarin use is associated with an enhanced immune status, and possibly even some anti-cancer effect. The re...

Detailed Description

In recent times, adverse publicity has affected the sales of hormone replacement therapies and the perception of women as to whether or not HRTs should be taken. While a number of brands are available...

Eligibility Criteria

Inclusion

  • Women taking oral Premarin at least for the last month with no urogenital anatomical abnormalities.
  • Women not taking HRT for at least one month with no urogenital anatomical abnormalities (controls).

Exclusion

  • Males.
  • Subjects who are not menopausal.
  • Less than 35 years of age.
  • Subjects with recurrent sexually transmitted disease.
  • Subjects with abnormal renal function (serum creatinine \>110umol/l, upper limit 90umol/l) or pyelonephritis.
  • Subjects receiving prednisone or immunosuppressive drugs,
  • Subjects who need to be treated for any urogenital infection or with any antimicrobial therapy.
  • Personal history of known or suspected estrogen-dependent neoplasia such as breast or endometrial cancer.
  • Undiagnosed abnormal vaginal bleeding.
  • Active hepatic dysfunction or disease, especially of the obstructive type.
  • Active thrombophlebitis, thrombosis or thromboembolic disorders.
  • Endometrial hyperplasia.
  • Subjects on anticoagulants, antidiabetic and antihypertensive agents

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00318318

Start Date

March 1 2006

End Date

February 1 2007

Last Update

July 9 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lawson Health Research Institute

London, Ontario, Canada, N6A 4V2